Nucleai
Romi Sadan has worked as a Medical Data Specialist at Nucleai since February 2022. Prior to that, they were employed at the Israeli Military Intelligence, where they served as the Webint Team Manager from July 2020 to August 2022 and as an Analyst from April 2018 to July 2020.
Romi Sadan began their education in 2017 by completing the "Schakim" program for Intelligence analysis training. Following this, they enrolled at Tel Aviv University in 2021 and are expected to complete their Doctor of Medicine (MD) degree in 2028. No specific field of study is provided.
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.